{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:42:51Z","timestamp":1787982171565,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.euroneuro.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T23:30:22Z","timestamp":1586647822000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The impact of sex and cannabis on clinical features in first\u2013admitted patients with psychosis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4527-1253","authenticated-orcid":false,"given":"Sara","family":"Arranz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Man\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-1016","authenticated-orcid":false,"given":"Dani","family":"Berg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Monserrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8114-0264","authenticated-orcid":false,"given":"Angel","family":"cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Sanchez-Gistau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.03.003_bib0001","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0447.1997.tb09925.x","article-title":"Reasons for substance use in schizophrenia","volume":"96","author":"Addington","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1751-7893.2012.00355.x","article-title":"Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs?","volume":"7","author":"Archie","year":"2013","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/15504263.2015.1113761","article-title":"Substance use in patients with first-episode psychosis: is gender relevant?","volume":"11","author":"Arranz","year":"2015","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0004","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11126-016-9426-2","article-title":"A study of the impact of cannabis on doses of discharge antipsychotic medication in individuals with schizophrenia or schizoaffective disorder","volume":"87","author":"Babatope","year":"2016","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0006","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-244X-13-326","article-title":"Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study","volume":"13","author":"Barbeito","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpsychires.2015.08.017","article-title":"Childhood trauma as a risk factor for psychosis: a sib-pair study","volume":"70","author":"Barrig\u00f3n","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-013-3157-y","article-title":"Cannabis use and cognitive functions in at-risk mental state and first episode psychosis","volume":"230","author":"Bugra","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.10.042","article-title":"The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014","volume":"170","author":"Carliner","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0010","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.psychres.2014.09.012","article-title":"Clinical and cognitive predictors of vocational outcome in first-episode schizophrenia: a prospective 3 year follow-up study","volume":"220","author":"Chang","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0011","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.jcp.0000236652.78168.ee","article-title":"Sex selection bias in schizophrenia antipsychotic trials","volume":"26","author":"Chaves","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.07.002","article-title":"Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis","volume":"114","author":"Cotton","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0013","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YCO.0000000000000243","article-title":"Issues related to sex differences in antipsychotic treatment","volume":"29","author":"Crawford","year":"2016","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2017.04.046","article-title":"The interaction of gender and cannabis in early phase psychosis","volume":"194","author":"Crocker","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rpsm.2017.04.002","article-title":"Substance abuse and gender differences in first episode psychosis: impact on hospital readmissions","volume":"11","author":"Crosas","year":"2018","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2010.04.007","article-title":"Cannabis use disorders in schizophrenia: effects on cognition and symptoms","volume":"120","author":"DeRosse","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0017","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients: clinical correlates and reasons for use","volume":"148","author":"Dixon","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0019","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.4088\/JCP.14m09369","article-title":"How age and gender predict illness course in a first-episode nonaffective psychosis cohort","volume":"77","author":"Drake","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S2045796016000123","article-title":"A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the northern finland birth cohorts 1966 and 1986","volume":"26","author":"Filatova","year":"2017","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0920-9964(99)00175-9","article-title":"Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients","volume":"43","author":"Gearon","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0023","first-page":"83","article-title":"Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review","volume":"42","author":"G\u00f3mez","year":"2014","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbp126","article-title":"Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use","volume":"37","author":"Gonz\u00e1lez-Pinto","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4088\/JCP.v69n0802","article-title":"Impact of cannabis and other drugs on age at onset of psychosis","volume":"69","author":"Gonz\u00e1lez-Pinto","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0026","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10550490490435795","article-title":"Substance-abusing schizophrenics: do they self-medicate?","volume":"13","author":"Goswami","year":"2004","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0027","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/09595230412331324563","article-title":"Reasons for cannabis use in men with and without psychosis","volume":"23","author":"Green","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2013.11.022","article-title":"Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health","volume":"136","author":"Haberstick","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0029","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00127-013-0700-4","article-title":"ABC Schizophrenia study: an overview of results since 1996","volume":"48","author":"H\u00e4fner","year":"2013","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0033291707000797","article-title":"Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study","volume":"38","author":"Harrison","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.schres.2015.11.027","article-title":"Cannabis use is associated with 3 years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N\u00a0=\u00a01119)","volume":"170","author":"Helle","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0032","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2017.01.005","article-title":"Gender differences in positive mental health among individuals with schizophrenia","volume":"74","author":"Jeyagurunathan","year":"2017","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0033","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-199008000-00007","article-title":"The positive and negative syndrome scale\u2013Spanish adaptation","volume":"178","author":"Kay","year":"1990","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0034","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.schres.2016.01.015","article-title":"Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders","volume":"171","author":"Kelley","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eurpsy.2014.10.007","article-title":"Reasons for cannabis use in first-episode psychosis: does strength of endorsement change over 12 months?","volume":"30","author":"Kolliakou","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0036","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.2174\/138161212802884807","article-title":"Why do psychotic patients use cannabis? Case series.","volume":"18","author":"Kolliakou","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0037","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","article-title":"Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis","volume":"36","author":"Koskinen","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0038","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00127-008-0384-3","article-title":"Gender differences in first episode psychosis","volume":"43","author":"K\u00f8ster","year":"2008","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14656566.2017.1288722","article-title":"How gender affects the pharmacotherapeutic approach to treating psychosis \u2013 a systematic review","volume":"18","author":"Lange","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.comppsych.2013.08.018","article-title":"One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?","volume":"55","author":"Lange","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0041","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0042","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pnpbp.2010.11.007","article-title":"Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency","volume":"35","author":"Makkos","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0043","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.psychres.2015.07.070","article-title":"Relationship between cannabis and psychosis: reasons for use and associated clinical variables","volume":"229","author":"Man\u00e9","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0044","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1017\/S0033291714000191","article-title":"Prognosis of schizophrenia in persons with and without a history of cannabis use","volume":"44","author":"Manrique-Garcia","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0447.2009.01483.x","article-title":"Illicit substance use and its correlates in first episode psychosis","volume":"121","author":"Mazzoncini","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0046","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00048670701732699","article-title":"Do women express and experience psychosis differently from men? Epidemiological evidence from the australian national study of low prevalence (Psychotic) disorders","volume":"42","author":"Morgan","year":"2008","journal-title":"Aust. New Zeal. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0047","first-page":"1","article-title":"Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr. Res. Treatment"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"6","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0049","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1751-7893.2007.00055.x","article-title":"Reasons for using substances in adolescents with and without psychosis","volume":"2","author":"Pencer","year":"2008","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0050","doi-asserted-by":"crossref","first-page":"21968","DOI":"10.3402\/qhw.v8i0.21968","article-title":"Walking the fine line: self-reported reasons for substance use in persons with severe mental illness","volume":"8","author":"Pettersen","year":"2013","journal-title":"Int. J. Qual. Stud. Health Well-being"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0051","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-0447.2000.00011.x","article-title":"Gender aspects in schizophrenia: bridging the border between social and biological psychiatry","author":"Riecher-R\u00f6ssler","year":"2000","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0052","article-title":"Perceived reasons for and consequences of substance abuse among patients with psychosis","volume":"12","author":"Saddichha","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0053","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12888-016-1124-y","article-title":"Challenges in detecting and diagnosing substance use in women in the acute psychiatric department: a naturalistic cohort study","volume":"16","author":"Sallaup","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ajad.12494","article-title":"Motivational changes of cannabis use prior to and during the course of schizophrenia","volume":"26","author":"Schnell","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0056","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the uk national eden study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0057","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1176\/appi.ajp.161.8.1324","article-title":"Gender differences in the prescribing of antipsychotic drugs","volume":"161","author":"Seeman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183613","article-title":"Cannabis use in male and female first episode of non-affective psychosis patients: long-term clinical, neuropsychological and functional differences","volume":"12","author":"Seti\u00e9n-Suero","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0059","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/NMD.0000000000000645","article-title":"Sex differences in psychiatric hospitalizations of individuals with psychotic disorders","volume":"205","author":"Shlomi Polachek","year":"2017","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09540261.2010.515965","article-title":"Gender differences in antipsychotic prescribing","volume":"22","author":"Smith","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0061","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0062","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eurpsy.2012.11.005","article-title":"Gender differences in first-episode psychosis at 5-year follow-up\u2013two different courses of disease? Results from the OPUS study at 5-year follow-up","volume":"29","author":"Thorup","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0063","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/eip.12235","article-title":"Gender differences in one-year outcomes of first-presentation psychosis patients in inner-city UK early intervention services","volume":"11","author":"Tseliou","year":"2017","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0064","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.eurpsy.2003.06.001","article-title":"Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample","volume":"18","author":"Usall","year":"2003","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","article-title":"Gender differences in response to antipsychotic treatment in outpatients with schizophrenia","volume":"153","author":"Usall","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0066","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"van der Meer","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0067","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2012.01.016","article-title":"Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study","volume":"137","author":"van Dijk","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.03.003_bib0068","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.149.4.552","article-title":"Past substance abuse and clinical course of schizophrenia","volume":"149","author":"Zisook","year":"1992","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:58:34Z","timestamp":1760378314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20300663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":68,"alternative-id":["S0924977X20300663"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.03.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of sex and cannabis on clinical features in first\u2013admitted patients with psychosis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}